scispace - formally typeset
G

Gustavo Pereira Cosenza

Researcher at Universidade Federal de Minas Gerais

Publications -  19
Citations -  517

Gustavo Pereira Cosenza is an academic researcher from Universidade Federal de Minas Gerais. The author has contributed to research in topics: Internal medicine & Pharmacopoeia. The author has an hindex of 9, co-authored 17 publications receiving 435 citations.

Papers
More filters
Journal ArticleDOI

Medicinal plants and other botanical products from the Brazilian Official Pharmacopoeia

TL;DR: The results of a thorough survey in the four editions of the Brazilian Official Pharmacopoeia (FBRAS), in a search for data about the plants and other botanical products included in them, showed a strong substitution of Native American medicinal plants by industrialized medicine and foreign medicinal plants in FBRAS as mentioned in this paper.
Journal ArticleDOI

Medicinal Plants Recommended by the World Health Organization: DNA Barcode Identification Associated with Chemical Analyses Guarantees Their Quality

TL;DR: It is concluded that DNA barcoding should be used in a complementary manner for species identification with chemical analyses to detect and quantify the required chemical compounds, thus improving the quality of this class of medicines.
Journal ArticleDOI

Traditional uses of American plant species from the 1st edition of Brazilian Official Pharmacopoeia.

TL;DR: A survey of the traditional uses of plants described in eighty-seven Monographs from the FBRAS in twenty bibliographies written from the 19th century to the 1970s, to encourage policy makers and the scientific public as a whole to engage in a strong debate in an attempt to improve and facilitate the pharmacological study of these species.
Journal ArticleDOI

Changes in the trade in native medicinal plants in Brazilian public markets

TL;DR: This study surveyed 15 public markets in different parts of Brazil in search of samples of 40 plants used in traditional medicine and present in first edition of Brazilian Official Pharmacopoeia, but found that only one-half of the samples were confirmed as the same plant species so named in FBRAS.